|
Home |
Cancer care innovation by digital therapeutics
 |
|
Home |
Cancer care innovation by digital therapeutics
|
- next-generation medical-grade decision-support system based on artificial intelligence and real-time patient monitoring during treatment, post-treatment and follow-up
- special applications for cancer and comorbidities to prevent and predict complications and to achieve day-to-day precision treatments, with an option to integrate circadian rhythm
- clinical performance, research and biomedical progress
- reduction of emergency treatments and admissions, economic performance, development of outpatient, homecare and "domomedicine"
- quality of life, quality-adjusted life years, survival
Population (Globocan 2018)
- World: 18.1 Million new cases per year (43,8 Million living patients after 5 years)
- Europe: 4.2 Million new cases per year (12,1 Million living patients after 5 years)
- World growth 2018-2040: over 60%
 |
 |
Last update : October 2018 |
